[ad_1]
OHSU researchers identify new tools for early cancer detection, treatment. MGN Image.
PORTLAND, OR – Researchers at Oregon Health & Science University’s Knight Cancer Institute are taking a unique approach to cancer research. In a report, they say the technologies they are exploring could transform how cancer is studied, detected, and treated by catching it earlier, when it’s more treatable and survival rates are highest.
“Early detection is one of the most important factors in surviving cancer,” said senior report author Luiz Bertassoni, D.D.S., Ph.D., director of the Knight Cancer Precision Biofabrication Hub, and a professor at the OHSU Knight Cancer Institute and the OHSU School of Dentistry. “These new technologies give us a window into how cancer forms and progresses, which opens the door to understanding early cancer, paving the way for earlier diagnosis and even predict cancer initiation.”

Simply put, the researchers are taking cancer cells from patients and allowing them to grow into tumors in the lab. The lab-grown models replicate the environment inside the human body and could unlock clues about how cancer begins.
“This is a really exciting time in cancer research,” Bertassoni said. “There is momentum in bringing together cancer biology, engineering and clinical treatment. There are so many avenues that didn’t exist before.”
Haylie Helms, M.S., is an OHSU graduate student in biomedical engineering and a graduate fellow of the International Alliance for Cancer Early Detection, and she is lead author on the report.
Her dissertation is on engineering and biofabrication of early cancer models. Specifically, she is researching single-cell 3D bioprinting as a tool for early cancer detection and treatment. Bioprinting allows for the creation of realistic, complex 3D tumor models that mimic cells in the human body. Those models can be used to study tumor development, responses to drugs and personalize treatment strategies, she said.

“We can first build a healthy tissue and use different tools to turn it into cancer. We can also take live cancer cells from a patient biopsy and add them into the model,” she added. “In the lab, we can watch and see, ‘Why does a precancerous lesion in one person stay that way and never turn into cancer and in another person, it becomes a malignant tumor?’”
This work at OHSU will also involve artificial intelligence, according to Helms. She noted that researchers are collecting so much data that the AI will help sort it all out for study.
Another benefit of this research would be a shift away from animal testing in cancer research.
More about:
[ad_2]
Tim Lantz
Source link
